Literature DB >> 11916182

The inhibitory effect of clindamycin on Lactobacillus in vitro.

A Aroutcheva1, J A Simoes, S Shott, S Faro.   

Abstract

OBJECTIVE: To evaluate the in vitro effect of varying concentrations of clindamycin on Lactobocillus spp.
METHODS: Concentrations of clindamycin ranging from 1.95-20,000 microg/ml were studied for their effect on the growth of six strains of Lactobacillus.
RESULTS: Clindamycin concentrations between 1.95-31.25 microg/ml had no statistically significant effect on growth of lactobacilli (p > 0.05). Concentrations 125 and 250 microg/ml had a bacteriostatic effect. The mean minimum inhibitory concentration (MIC) for studied Lactobacillus strains was determined as 1,000 microg/ml.
CONCLUSION: High concentrations of clindamycin achieved in the vagina by intravaginal application might be inhibitory for Lactobacillus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11916182      PMCID: PMC1784659          DOI: 10.1155/S1064744901000394

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  21 in total

1.  [Bacterial vaginosis. Relation between the vaginal flora and the vaginal epithelial cells under different treatments. Ultrastructural study].

Authors:  E Flores Rivera; G Casanova Roman; M Beltrán; M A González Jimenez; H Villegas Castrejon
Journal:  Ginecol Obstet Mex       Date:  1997-05

2.  Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.

Authors:  P G Larsson; J J Platz-Christensen; K Dalaker; K Eriksson; L Fåhraeus; K Irminger; F Jerve; B Stray-Pedersen; P Wölner-Hanssen
Journal:  Acta Obstet Gynecol Scand       Date:  2000-05       Impact factor: 3.636

3.  Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.

Authors:  J Paavonen; C Mangioni; M A Martin; C P Wajszczuk
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

4.  Anaerobic bacteria in nonspecific vaginitis.

Authors:  C A Spiegel; R Amsel; D Eschenbach; F Schoenknecht; K K Holmes
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

5.  Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra.

Authors:  A S Bayer; A W Chow; N Concepcion; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

6.  [Gardnerella vaginalis: transport, microscopy, testing resistance].

Authors:  T Altrichter; W R Heizmann
Journal:  Geburtshilfe Frauenheilkd       Date:  1994-11       Impact factor: 2.915

7.  Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.

Authors:  D G Ferris; M S Litaker; L Woodward; D Mathis; J Hendrich
Journal:  J Fam Pract       Date:  1995-11       Impact factor: 0.493

8.  Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight.

Authors:  M R Joesoef; S L Hillier; G Wiknjosastro; H Sumampouw; M Linnan; W Norojono; A Idajadi; B Utomo
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

9.  The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli.

Authors:  K J Agnew; S L Hillier
Journal:  Sex Transm Dis       Date:  1995 Sep-Oct       Impact factor: 2.830

10.  In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.

Authors:  S Shanker; M Toohey; R Munro
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

View more
  9 in total

1.  Mode of action and safety of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050.

Authors:  S Riazi; S E Dover; M L Chikindas
Journal:  J Appl Microbiol       Date:  2012-07-24       Impact factor: 3.772

2.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

3.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

4.  Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.

Authors:  M N Austin; R H Beigi; L A Meyn; S L Hillier
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.

Authors:  Jin Ku Kang; Jae Sam Hwang; Hyo Jung Nam; Keun Jae Ahn; Heon Seok; Sung-Kuk Kim; Eun Young Yun; Charalabos Pothoulakis; John Thomas Lamont; Ho Kim
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

Review 6.  Effects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review.

Authors:  Roghayeh Afifirad; Amir Darb Emamie; Rezvan Golmoradi Zadeh; Parisa Asadollahi; Roya Ghanavati; Atieh Darbandi
Journal:  Int J Clin Pract       Date:  2022-04-21       Impact factor: 3.149

7.  Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester.

Authors:  Yevgeniy Turovskiy; Thomson Cheryian; Ammar Algburi; Ruth E Wirawan; Paul Takhistov; Patrick J Sinko; Michael L Chikindas
Journal:  Infect Dis Obstet Gynecol       Date:  2012-09-17

8.  Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study.

Authors:  Christopher J Martoni; Amalie Kruse Sigersted Frederiksen; Anders Damholt; Gregory Leyer
Journal:  Int J Womens Health       Date:  2022-01-18

9.  Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Piotr B Heczko; Anna Tomusiak; Paweł Adamski; Artur J Jakimiuk; Grzegorz Stefański; Aleksandra Mikołajczyk-Cichońska; Magdalena Suda-Szczurek; Magdalena Strus
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.